Latest Articles

Publication Date
Data pharmacovigilance analysis of medroxyprogesterone-related adverse events in the FDA adverse event reporting system.

Medroxyprogesterone acetate (MPA), a steroid progesterone, is widely used to treat endometriosis, menstrual disorders, and uterine bleeding in clinical practice. However, the safety profile of MPA requires comprehensive evaluation.

Published: Jan. 31, 2025, midnight
ESTROGEN-PROGESTINS AND ENDOMETRIOSIS-ASSOCIATED DEPRESSION:OF CAUSATION, BIAS, AND CONFOUNDING.

Published: Jan. 31, 2025, midnight
Prevalence and sociodemographic distribution of endometriosis symptoms and indicators in Denmark.

Endometriosis is characterized by a range of non-specific symptoms which may contribute to the significant delay in diagnosis. Knowledge about the distribution of endometriosis symptoms across different geographical regions as …

Published: Jan. 31, 2025, midnight
The NLRP3 activation-related signature predicts the diagnosis and indicates immune characteristics in endometriosis.

Endometriosis (EMS) is a prevalent gynecological disease that leads to chronic pelvic pain and infertility in women of reproductive age. However, the underlying pathogenic genes and effective treatment for EMS …

Published: Jan. 31, 2025, midnight
Decreased expression of miR-200a and miR-223-3p in endometriosis during the secretory phase of menstrual cycle: Insights from a case-control study on molecular biomarkers and disease-related infertility.

Endometriosis (EM) is a condition that causes infertility with decreasing uterine receptivity. It is reported that it affects about 20-25% of all infertile women. Some genetic markers play a crucial …

Published: Jan. 31, 2025, midnight
Molecular Subtyping Predicts Recurrence and Survival Benefits in Endometrial Cancer - OncLive

Molecular Subtyping Predicts Recurrence and Survival Benefits in Endometrial Cancer OncLive

Published: Jan. 30, 2025, 10:54 p.m.
Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer - OncLive

Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer OncLive

Published: Jan. 30, 2025, 10:29 p.m.
Australian Scientists Develop A Simple And Non-Invasive Test To Diagnose Endometriosis, Helping 190 Million Women Worldwide With Their Physical And Reproductive Health - Twisted Sifter

Australian Scientists Develop A Simple And Non-Invasive Test To Diagnose Endometriosis, Helping 190 Million Women Worldwide With Their Physical And Reproductive Health Twisted Sifter

Published: Jan. 30, 2025, 5:56 p.m.
Reproductive Endocrine Disorders: A Comprehensive Guide to the Diagnosis and Management of Infertility, Polycystic Ovary Syndrome, and Endometriosis - Cureus

Reproductive Endocrine Disorders: A Comprehensive Guide to the Diagnosis and Management of Infertility, Polycystic Ovary Syndrome, and Endometriosis Cureus

Published: Jan. 30, 2025, 8:39 a.m.
Kokilaben Hospital Becomes India’s First European-Certified Endometriosis Center, Revolutionizing Women’s Healthcare - Prittle Prattle News

Kokilaben Hospital Becomes India’s First European-Certified Endometriosis Center, Revolutionizing Women’s Healthcare Prittle Prattle News

Published: Jan. 30, 2025, 7:08 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!